12
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To the Editor, We read with great interest the letter of Landi et al. 1 in which the authors reported solid data about the persistence of virus particles in SARS-CoV-2 patients after the acute phase of epidemic infection. In particular, authors found that 20,6% of patients were tested positive again after at least one month from post-acute care admission (on a total of 29 examined patients). Results showed by Landi and colleagues 1 strongly suggest that a significant number of recovered SARS-CoV-2 patients still could be potentially asymptomatic carriers of the virus. According to these data authors also suggest the modification of the current Italy guidelines for the management of SARS-CoV-2 patients 2 proposing two consecutive negative RT-PCR test results together with the clinical evidence of symptoms improvement before discharge from the hospital and discontinuation of quarantine. In our opinion this study highlighted a great issue for the public health in terms of both virus spread control and safety of healthcare professionals. Indeed, asymptomatic carriers of the virus could transmit the infection during the frequently post-admission visits to which they are often subjected. Our recent investigation can extend the considerations reported by Landi et al. 1 shedding new light on the capability of SARS-CoV-2 particles to also persist in deceased persons. In fact, we studied the persistence of SARS-CoV-2 by real time-PCR in 24 hours post-mortem swabs of subjects who died from SARS-CoV-2 infection. RT-PCR analysis targeted the common envelope (E) gene, the specific nucleocapsid (N) and RNA-dependent-RNA-polymerase (RdRp) genes complying with the international validated protocols 3 both at T0 and after 24 hours. The results of rRT-PCR test are showed as cycle-threshold (Ct) values. Ct-values less than 35 were considered as positive tests. Experimental procedures were performed according to the authorization of the independent ethics committee of the “Policlinico Tor Vergata” for the study of the presence of SARS-CoV-2 in the organic tissues and fluids obtained from autoptic examinations (#77.20). 15 patients with SARS-CoV-2 interstitial pneumonia were included in this study, 8 males and 6 females (age range 46-92, mean 73,1 +/- 11,7). The duration of hospitalization ranged from 1 to 108 days (mean 22,1 +/- 13,4). All patients had more than one associated disease (8 had heart failure, arrhythmia or ischemic heart disease, 6 hypertension, 6 dementia, 3 chronic renal failure, 2 neoplasms, 2 diabetes, 2 obesity, 1 recent kidney transplantation, 1 stroke). RT-PCR investigations showed that SARS-CoV-2 viral RNA was still detectable in 60% of cases 24 hours after death. Noteworthy, our data showed an increase of the viral load in more of 50% of positive individuals 24 hours post-mortem (decrease of Ct value). It is important to note that more of 20% of deceased were positive for all evaluated genes (E, N and RdRp) also after 24 hours. This fact allows to consider the autoptic exam of a SARS-CoV-2 positive deceased an highly dangerous procedure also after 24 hours. From biological point of view, this unexpected finding can be explained by the increase in chest pressure due to the formation of intestinal gas with consequent compression on the diaphragm (Fig. 1 A) and / or by post-mortem cell lysis (fig. 1B). In this case, there would be an indirect and greater release of the alveolar contents and virus-containing secretions in the upper airways. In addition, it is possible to hypothesize the existence of a post-mortem time window in which spike positive alive human cells can be infected by SARS-COV-2 and release great amount of viral particles, especially in absence of circulating immune cells (Fig. 1C). Indeed, several studies on animal models demonstrated that many cells remain alive and thriving after an organism's death. Amazingly, some of these increase their activity in the first hours after death 4 . This interesting discovery has been dubbed the “Twilight of Death,” which refers to the time frame between death and body's decomposition where not all of the body's cells are yet dead. The authors suggest that the death phenomenon is more like a slow shutdown process and not the simple off-switch many imagine it to be. Thus, pathological process such as viral infections, could continue, or even increase, in the first hours after death. However, we cannot exclude a false negative result on the first test. According to literature, false negatives may be due mainly to inappropriate sample taking or transport, or a low viral load, below the sensitivity limit of the technique. 5 To minimize the risk of sampling errors, in this study all nasopharyngeal swabs were taken by a single well-trained operator using a previously described standard operating procedure. 6 Therefore, we believe that further possible explanations cannot be excluded, especially when considering the potential role of post-mortal transformative phenomena. Figure 1 Hypothesis about the SARS-CoV-2 persistence in human body after death. A) The increase in chest pressure due to the formation of intestinal gas with consequent compression on the diaphragm can push out the SARS-CoV-2 particles from lower to upper airways. B) The lysis of SARS-CoV-2 infected cells that occur after death can release a large amount of viral particles in the upper airways. C) In the first hours after death the SARS-CoV-2 can infect alive cells thus increasing the viral load. Created in Biorender.com. Figure 1 The peculiar results emerged from our study can be considered of great scientific interest and justify the need to adopt appropriate protective measures by both the medico-legal team in the surveys on the investigative scenes and the staff of the morgue. 7 , 8 Nonetheless, even in a hospital setting when a diagnostic autopsy is required, our results highlight the importance of obtaining not only one post mortem swab, but at least two, if not three, consecutive swabs before a patient can be considered SARS-CoV-2-negative with a reasonable degree of certainty. This is particularly true for patients who died during the transfer to the hospital or without medical intervention, for whom autopsy is required with no exhaustive clinical data. Declaration of Competing Interest All authors have no conflict of interest. Go to: Abbreviations Ct: cycle-threshold E: envelope N: nucleocapsid RdRp: RNA-dependent-RNA-polymerase RT-PCR: real-time- Polymerase Chain Reaction Ethics approval and consent to participate The study was approved by the Ethics Committee of the Policlinico Tor vergata (Rome, Italy) (#77.20). Consent for publication Not applicable. Availability of data and material All the data and material are available by emailing the corresponding author. Consent for publication The author gives consent for publication of this paper. Funding None Authors' contributions MS, SM and AM coordinated the overall study. MS, SM, FS, OS, and AM were involved in the concept and the design of the study. MS, SM, and AM drafted the manuscript. FS, BC, MC, LA, MM, EG, MT, SB, and LTM contributed to the acquisition and the interpretation of the data. All the authors revised the manuscript and approved its final version.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Biosafety considerations for autopsy.

          An autopsy may subject prosectors and others to a wide variety of infectious agents, including bloodborne and aerosolized pathogens such as human immunodeficiency virus, hepatitis B and C viruses, and Mycobacterium tuberculosis. Other hazards include toxic chemicals (e.g., formalin, cyanide, and organophosphates) and radiation from radionuclides used for patient therapy and diagnosis. These risks can be substantially mitigated through proper assessment, personal protective equipment, appropriate autopsy procedures, and facility design.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19

            SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a coronavirus responsible for COVID-19 (coronavirus disease 2019) which resulted in a cluster of cases of pneumonia that originated in China around 31 December 2019 and has subsequently spread across the globe. Currently, COVID-19 represents a health emergency worldwide, leading, in severe cases, to pneumonia, severe acute respiratory syndrome, multiorgan dysfunction or failure, and death. In the context of limited scientific knowledge and evidence of SARS-CoV-2 infection, guidance is becoming increasingly necessary for pathologists who have to perform postmortem investigations on COVID-19 cases. The aim of the present report is to share a procedure applicable to cases of COVID-19-related death, particularly in cases of death without medical intervention and in the absence of an ascertained SARS-CoV-2 infection and/or COVID-19 diagnosis, therefore providing support for diagnostic activity in the present COVID-19 pandemic. For this purpose, a standard operating procedure for correct swab collection, autopsy investigation and tissue sampling is provided.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              COVID-19 and post-mortem microbiological studies ☆

              We review the microbiological aspects of COVID-19 infection and present the microbiological studies that should be performed in forensic cases. We describe the taxonomic characteristics of the virus, its relationship with the coronaviridae family and its genetic structure. We briefly present the clinical and pathological characteristics of COVID-19 infection, as well as the co-infections that could be associated with this virus. In the laboratory, PCR is a first-choice technique in the acute phase of the infection, together with antigen and serological studies. Finally, we describe the main objectives of microbiological studies in the deceased in relation to the COVID-19 pandemic, as well as the main post-mortem microbiological analysis to be carried out in the medico-legal context. The microbiological analysis should aim to detect both SARS-CoV-2 and coinfections, which may also contribute to the cause of death.
                Bookmark

                Author and article information

                Journal
                J Infect
                J Infect
                The Journal of Infection
                The British Infection Association. Published by Elsevier Ltd.
                0163-4453
                1532-2742
                17 February 2021
                17 February 2021
                Affiliations
                [1 ]Anatomic Pathology, Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, Rome (RM) 00133 Italy
                [2 ]Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131, Rome, Italy
                [3 ]Forensic Medicine, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Italy
                [4 ]Division of Clinical Biochemistry and Clinical Molecular Biology; Department of Experimental Medicine, University of Rome "Tor Vergata", Italy
                [5 ]Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy
                [6 ]Tor Vergata Oncoscience Research (TOR), University of Rome "Tor Vergata", Italy
                Author notes
                [* ]Corresponding author: Prof. Alessandro Mauriello, MD, Anatomic Pathology, Department of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, Rome (RM) 00133, Italy. Phone: +39 0620903908.
                [#]

                Manuel Scimeca and Silvestro Mauriello equally first author.

                Article
                S0163-4453(21)00083-9
                10.1016/j.jinf.2021.02.016
                7889030
                33609587
                0566bec5-a0fc-454a-bb71-1f5cee584bf0
                © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 14 February 2021
                Categories
                Letter to the Editor

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article